Drug Patents owned by Siga Technologies

1. Drug name - TPOXX

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8124643 SIGA TECHNOLOGIES Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
Jun, 2024

(1 year, 8 months from now)

US9339466 SIGA TECHNOLOGIES Polymorphic forms of ST-246 and methods of preparation
Mar, 2031

(8 years from now)

CN101702904A SIGA TECHNOLOGIES Chemicals, Compositions, And Methods For Treatment And Prevention Of Orthopoxvirus Infections And Associated Diseases
Aug, 2015

(7 years ago)

CN105175311A SIGA TECHNOLOGIES Polymorphic Forms Of St-246 And Preparation Method
Mar, 2019

(3 years ago)

CN105111130A SIGA TECHNOLOGIES Polymorphic Form St-246 And Preparation Method
Apr, 2019

(3 years ago)

CN105111131A SIGA TECHNOLOGIES Polymorphic Form St-246 And Preparation Method
May, 2019

(3 years ago)

CN103068232A SIGA TECHNOLOGIES Polymorph Form St-246 And Preparation Method
Mar, 2031

(8 years from now)

CN103068232B SIGA TECHNOLOGIES Polymorph Form St-246 And Preparation Method
Mar, 2031

(8 years from now)

EP1638938A2 SIGA TECHNOLOGIES Compounds, Compositions And Methods For Treatment And Prevention Of Orthopoxvirus Infections And Associated Diseases
Jun, 2024

(1 year, 8 months from now)

EP1638938A4 SIGA TECHNOLOGIES Compounds, Compositions And Methods For Treatment And Prevention Of Orthopoxvirus Infections And Associated Diseases
Jun, 2024

(1 year, 8 months from now)

EP1638938B1 SIGA TECHNOLOGIES Compounds, Compositions And Methods For Treatment And Prevention Of Orthopoxvirus Infections And Associated Diseases
Jun, 2024

(1 year, 8 months from now)

EP2549871A4 SIGA TECHNOLOGIES Polymorphic Forms St-246 And Methods Of Preparation
Mar, 2031

(8 years from now)

EP2549871B1 SIGA TECHNOLOGIES Polymorphic Form St-246 And Methods Of Preparation
Mar, 2031

(8 years from now)

EP2549871A1 SIGA TECHNOLOGIES Polymorphic Form St-246 And Methods Of Preparation
Mar, 2031

(8 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8802714 SIGA TECHNOLOGIES Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases Jun, 2024

(1 year, 8 months from now)

US8530509 SIGA TECHNOLOGIES Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases Jun, 2024

(1 year, 8 months from now)

US7737168 SIGA TECHNOLOGIES Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases May, 2027

(4 years from now)

US8039504 SIGA TECHNOLOGIES Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases Jul, 2027

(4 years from now)

Drugs and Companies using TECOVIRIMAT ingredient

Treatment: Treatment of human smallpox disease caused by variola virus in adults and pediatric patients weighing at least 13 kg

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
200MG CAPSULE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.